The goal of this clinical trial is to test the safety and effectiveness of a single dose of RABI-767 given by endoscopic ultrasound (EUS) guided peripancreatic injection in participants with predicted severe acute pancreatitis. The main question the鈥�
- Investigator
- John G Lieb
- Status
- Accepting Candidates
- Ages
- 18 Years - 85 Years
- Sexes
- All